首页> 外文期刊>MBio >Coagulase and Efb of Staphylococcus aureus Have a Common Fibrinogen Binding Motif
【24h】

Coagulase and Efb of Staphylococcus aureus Have a Common Fibrinogen Binding Motif

机译:金黄色葡萄球菌的凝固酶和Efb具有共同的纤维蛋白原结合基序

获取原文
获取外文期刊封面目录资料

摘要

ABSTRACT Coagulase (Coa) and Efb, secreted Staphylococcus aureus proteins, are important virulence factors in staphylococcal infections. Coa interacts with fibrinogen (Fg) and induces the formation of fibrin(ogen) clots through activation of prothrombin. Efb attracts Fg to the bacterial surface and forms a shield to protect the bacteria from phagocytic clearance. This communication describes the use of an array of synthetic peptides to identify variants of a linear Fg binding motif present in Coa and Efb which are responsible for the Fg binding activities of these proteins. This motif represents the first Fg binding motif identified for any microbial protein. We initially located the Fg binding sites to Coa’s C-terminal disordered segment containing tandem repeats by using recombinant fragments of Coa in enzyme-linked immunosorbent assay-type binding experiments. Sequence analyses revealed that this Coa region contained shorter segments with sequences similar to the Fg binding segments in Efb. An alanine scanning approach allowed us to identify the residues in Coa and Efb that are critical for Fg binding and to define the Fg binding motifs in the two proteins. In these motifs, the residues required for Fg binding are largely conserved, and they therefore constitute variants of a common Fg binding motif which binds to Fg with high affinity. Defining a specific motif also allowed us to identify a functional Fg binding register for the Coa repeats that is different from the repeat unit previously proposed. IMPORTANCE Staphylococcus aureus infections are a major health problem that affects an estimated 50 million people globally and causes the death of about 20,000 Americans each year. A number of experimental vaccines have been developed during the past years. However, these vaccines have all failed in clinical trials. The ability of S.?aureus to form an Fg shield surrounding and protecting bacterial cells from clearance may explain why the vaccines are failing. Furthermore, S.?aureus coagulase can induce the formation of a fibrin(ogen) shield in experimental abscess models which surrounds and protects bacteria in the microcolony from clearance. In this study, we identified for the first time a microbial Fg binding motif. Variants of this motif are present in coagulase and Efb. Our results provide a molecular basis for the rational design of inhibitors that could potentially prevent the formation of the obstructing Fg shield.
机译:摘要Coagulase(Coa)和Efb是金黄色葡萄球菌分泌的蛋白,是葡萄球菌感染中的重要毒力因子。 Coa与纤维蛋白原(Fg)相互作用,并通过凝血酶原的激活诱导纤维蛋白(原)凝块的形成。 Efb将Fg吸引到细菌表面并形成屏蔽层,以保护细菌免受吞噬作用的清除。该通报描述了使用合成肽阵列鉴定Coa和Efb中存在的线性Fg结合基序的变体,这些变体负责这些蛋白的Fg结合活性。该基序代表针对任何微生物蛋白鉴定的第一个Fg结合基序。我们最初是通过在酶联免疫吸附测定型结合实验中使用Coa的重组片段,将Fg结合位点定位于含有串联重复序列的Coa的C末端无序片段。序列分析显示,该Coa区包含较短的片段,其序列与Efb中的Fg结合片段相似。丙氨酸扫描方法使我们能够鉴定Coa和Efb中对Fg结合至关重要的残基,并定义两种蛋白质中的Fg结合基序。在这些基序中,Fg结合所需的残基在很大程度上是保守的,因此它们构成了以高亲和力结合Fg的常见Fg结合基序的变体。定义一个特定的基序还使我们能够为Coa重复序列识别一个功能性Fg结合寄存器,该寄存器与先前提出的重复序列不同。重要事项金黄色葡萄球菌感染是一个重大的健康问题,全球约有5000万人受到影响,每年造成约20,000美国人死亡。在过去的几年中,已经开发了许多实验疫苗。但是,这些疫苗在临床试验中都失败了。金黄色葡萄球菌形成包围和保护细菌细胞免于清除的Fg屏蔽的能力可能解释了疫苗为何失败的原因。此外,金黄色葡萄球菌凝固酶可以在脓肿实验模型中诱导纤维蛋白(原)屏蔽层的形成,脓肿模型包围并保护小菌落中的细菌免受清除。在这项研究中,我们首次确定了微生物Fg结合基序。该基序的变体存在于凝固酶和Efb中。我们的结果为抑制剂的合理设计提供了分子基础,该抑制剂可以潜在地阻止阻碍性Fg盾的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号